Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6201348 | 0.90 | PARP1 (0.76) | PARP1PARP2 | |
| SCHEMBL6202565 | 0.88 | PARP1 (0.60) | PARP1PARP2 | |
| SCHEMBL7163111 | 0.88 | PARP1 (0.79) | PARP1 | |
| SCHEMBL6202744 | 0.86 | PARP1 (1.00) | PARP1 | |
| SCHEMBL7161746 | 0.86 | PARP1 (1.00) | PARP1 | |
| SCHEMBL7554564 | 0.85 | PARP1 (0.80) | PARP1 | |
| SCHEMBL5074040 | 0.84 | PARP1 (0.76) | PARP1 | |
| SCHEMBL7162218 | 0.82 | PARP1 (1.00) | PARP1PARP2 | |
| SCHEMBL831830 | 0.81 | PARP1 (1.00) | PARP1 | |
| SCHEMBL7156700 | 0.81 | PARP1 (0.73) | PARP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1208104-B1 | TRICYCLIC INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASES | AGOURON PHARMA (US) | 2005-01-19 | — | — | EP | disclosed |
| US-6548494-B1 | 3,4-dihydro-2H-(1,4)diazepino(6,7,1-hi)indol-1-one or 1-thione derivatives where indole C3 could also be N; use treating cancers as well as stroke, head trauma, and neurodegenerative diseases | AGOURON PHARMACEUTICALS, INC. | 2003-04-15 | — | — | US | disclosed |
| EP-1208104-A2 | TRICYCLIC INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASES | AGOURON PHARMACEUTICALS, INC. (US) | 2002-05-29 | — | — | EP | disclosed |
| WO-2001016136-A2 | TRICYCLIC INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASES | AGOURON PHARMACEUTICALS, INC. (US) | 2001-03-08 | — | — | WO | disclosed |